We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Hashim Ahmed

Hashim U. Ahmed MD

Professor of Urology, Division of Surgery, Department of Surgery and Cancer, Imperial College London; Chair of Urology and Consultant Urological Surgeon, Imperial Urology, Imperial College Healthcare NHS Trust; Chair, NCRI Prostate Group, London, United Kingdom

Hashim Ahmed is Chair and Professor of Urology at Imperial College London, UK, and leads an extensive portfolio of translational and clinical trials work in improving the diagnosis and treatment of prostate cancer and benign prostate hyperplasia.

Disclosures

Dr. Ahmed discloses the following:

  • Grant funding from Wellcome Trust, Medical Research Council (UK), Cancer Research UK, Prostate Cancer UK, The Urology Foundation, BMA Foundation and the NIHR (UK) Imperial Biomedical Research Centre.
  • Grant funding for trials received from Sonacare Inc, Trod Medical, and Sophiris Bio.
  • Consultant for trials for Sophiris Bio.
  • Proctor for prostate HIFU (Sonacare Inc), prostate cryotherapy (BTG/Galil, now Boston) and Rezum (Boston Scientific).